| 1 | The effect of folic acid on the development of stomach and other gastrointestinal cancers显示文摘Objective To evaluate the roles of folic acid and β-carotene in the chemoprevention of gastric and other gastrointestinal (GI) cancers. Methods In a randomized, double-blind, placebo-controlled trial, a total of 216 patients with atrophic gastritis were randomly assigned to one of the four groups: ①folate (FA, 20 mg per day plus vitamin B 12 1 mg, intramuscularly, per month for one year, then 20 mg two times a week plus 1 mg per three months for the next year); ②natural β-carotene (N-βC, 30 mg per day for first year, then 30mg two times a week for the next); ③synthetic β-carotene (S-βC, administered as in N-βC); and ④placebo. Follow-ups continued from 1994 to 2001. Results A total of 7 new cases of gastrointestinal cancers were diagnosed with 3 stomach, 1 colon and 1 esophageal cancers occurring in the placebo group; 1 stomach cancer in both of the N-βC and S-βC groups, and no cancer occurring in FA group. In terms of GI cancers, there was a significant reduction in the FA group, compared with the placebo group (P= 0.04). A similar trend was observed in both N-βC and S-βC groups (P=0.07-0.08). Taken together, the three intervention groups displayed a highly significant decrease in occurrence (P=0.004, vs placebo), and a lower risk for GI cancers (OR=0.12; 95% confidence interval, 0.03-0.51). For development of gastric cancer, any one of the three active-treated groups did not reach statistically significant reduction. The FA group showed obvious improvement of the gastric mucosal lesions with more patients displaying lesions reversed or stable atrophy and inflammation (P=0.04), reversed intestinal metaplasia (P=0.06) at the end of follow-up, and reversed displasia (P=0.017) at 12 months. Two cases of false jaundice were found in β-carotene groups with no influence on administration, and no side-effects were reported in FA group. Conclusions This trial revealed the interventional effect of folic acid on the development of GI cancers, a similar effect of β-carotene was also detected. Also, folic acid may be of use to treat atrophic gastritis by preventing or reversing the precancerous lesions. | 朱舜时 施尧 胡运彪 李蓉蓉 汪敏 周怡和 金冠球 谢宇野Shanghai Navy Hospital Shanghai 200081 China 邬桂泉 夏德凰Shanghai Putuo People's Hospital 钱珍华 宋海连Shanghai Traditional and Western Medical Integrated Hospital 屠伯强 张丽冬 萧树东 | 2003 | Chinese Medical Journal2003，，1： | 42 |
| 2 | 基线体质指数与男性胃癌发病关系的前瞻性队列研究显示文摘目的研究基线BMI与男性胃癌发病风险之间的关联。方法基于开滦队列(2006-2015年)男性人群,收集身高、体重等流行病学信息。每两年随访1次,收集胃癌发病结局资料;检索开滦附属医院医疗信息系统、开滦集团保险系统、唐山市医疗保险系统,补充收集随访过程中可能遗漏的胃癌新发病例。以体重正常(18.5 kg/m2≤BMI<24.0 kg/m2)人群为参照组,利用Cox风险比例模型分析基线BMI与男性胃癌发病风险的关联,计算发病风险比(HR)及其95%CI。结果共纳入109600名男性,共随访860399.79人年,中位随访时间8.8年,收集胃癌新发病例272例。和正常体重人群相比,调整年龄、文化程度、吸烟状态、饮酒频率、粉尘暴露、食盐习惯、饮茶习惯等潜在的混杂因素后,体重过轻人群(BMI<18.5 kg/m2)胃癌发病风险升高(HR=2.11,95%CI:1.23~3.62),超重/肥胖与胃癌发病风险无统计学关联。按照年龄、文化程度、吸烟、饮酒、饮茶、粉尘暴露等进行分层分析,结果显示,高年龄组、高文化程度、不吸烟、不饮酒、不饮茶、有粉尘暴露人群中,低体重与胃癌发病关联依然有统计学意义。结论体重过轻可能增加男性胃癌发病风险,且该关联受年龄、文化程度、吸烟、饮酒、饮茶、粉尘暴露等因素影响。 | 魏锣沛 李霓 王刚 温艳 吕章艳 冯小双 李鑫 陈玉恒 陈宏达 陈朔华 任建松 石菊芳 崔宏 吴寿岭 代敏 赫捷 | 2019 | 中华流行病学杂志2019，40，12： | 3 |
您所在的机构暂未开通此部分的功能，请联系管理员